Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With Attention-deficit/Hyperactivity Disorder.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2018
Price : $35 *
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 11 Aug 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 New trial record